Global Site License: US$ 875.00
Introduction
This databook provides key data and information on the Analgesics Market in Western Europe (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
The analgesics category was valued at $5,758.9m in 2009, representing a CAGR of 2.6% since 2004.
By the end of 2014, the analgesics category will be worth $6,415.9m, with an expected CAGR of 2.2% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 48.7% of the total value) followed by other analgesics and aspirin, with a 19.6% and 17.5% market share, respectively. Ibuprofen accounts for the remaining 14.2% share.
Bayer AG is the market leader with a 16.8% share of the market.
Reasons to Purchase
Introduction
This databook provides key data and information on the Analgesics Market in Western Europe (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
The analgesics category was valued at $5,758.9m in 2009, representing a CAGR of 2.6% since 2004.
By the end of 2014, the analgesics category will be worth $6,415.9m, with an expected CAGR of 2.2% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 48.7% of the total value) followed by other analgesics and aspirin, with a 19.6% and 17.5% market share, respectively. Ibuprofen accounts for the remaining 14.2% share.
Bayer AG is the market leader with a 16.8% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Analgesics Market in Western Europe (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements
CHAPTER 1 EXECUTIVE SUMMARY
Summary category level: Analgesics
CHAPTER 2 DEFINITION
CHAPTER 3 CATEGORY ANALYSIS: ANALGESICS
Value analysis (US Dollar), 2004−09
Value analysis (US Dollar), 2009−14
Company share analysis
Distribution analysis
CHAPTER 4 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Analgesics, Western Europe, value by segment ($m), 2004−14
Figure 2: Analgesics, Western Europe, category growth comparison, by value, 2004−14
Figure 3: Analgesics, Western Europe, company share (top five companies) by value (%), 2008−09
Figure 4: Analgesics, Western Europe, distribution channels by value (%), 2008−09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Analgesics category definitions
Table 2: Analgesics distribution channels
Table 3: Analgesics, Western Europe, value by segment ($m), 2004−09
Table 4: Analgesics, Western Europe, value forecast by segment ($m), 2009−14
Table 5: Analgesics, Western Europe, company share (top 20 companies) by value (%), 2008−09
Table 6: Analgesics, Western Europe, value by company ($m), 2008−09
Table 7: Analgesics, Western Europe, distribution channels by value (%), 2008−09
Table 8: Analgesics, Western Europe, value by distribution channel ($m), 2008−09
Summary category level: Analgesics
CHAPTER 2 DEFINITION
CHAPTER 3 CATEGORY ANALYSIS: ANALGESICS
Value analysis (US Dollar), 2004−09
Value analysis (US Dollar), 2009−14
Company share analysis
Distribution analysis
CHAPTER 4 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Analgesics, Western Europe, value by segment ($m), 2004−14
Figure 2: Analgesics, Western Europe, category growth comparison, by value, 2004−14
Figure 3: Analgesics, Western Europe, company share (top five companies) by value (%), 2008−09
Figure 4: Analgesics, Western Europe, distribution channels by value (%), 2008−09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Analgesics category definitions
Table 2: Analgesics distribution channels
Table 3: Analgesics, Western Europe, value by segment ($m), 2004−09
Table 4: Analgesics, Western Europe, value forecast by segment ($m), 2009−14
Table 5: Analgesics, Western Europe, company share (top 20 companies) by value (%), 2008−09
Table 6: Analgesics, Western Europe, value by company ($m), 2008−09
Table 7: Analgesics, Western Europe, distribution channels by value (%), 2008−09
Table 8: Analgesics, Western Europe, value by distribution channel ($m), 2008−09
